| Trial ID: | L0355 |
| Source ID: | NCT01437943
|
| Associated Drug: |
Aliskiren
|
| Title: |
Effect of Short Term Aliskiren Treatment in Kidney Transplant Patients
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT01437943/results
|
| Conditions: |
Kidney Disease|Kidney Failure, Chronic
|
| Interventions: |
DRUG: Aliskiren|DRUG: Placebo
|
| Outcome Measures: |
Primary: Effect of Aliskiren on Kidney Metabolism, Evaluation of aliskiren on kidney metabolism by P-MR spectroscopy, 180 days (completion of treatment) |
|
| Sponsor/Collaborators: |
Sponsor: Brigham and Women's Hospital | Collaborators: Novartis
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
10
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2010-04
|
| Completion Date: |
2012-01
|
| Results First Posted: |
2017-05-01
|
| Last Update Posted: |
2017-05-01
|
| Locations: |
Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01437943
|
